markov model treeage pro 2011 (treeage software)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

treeage software markov model treeage pro 2011
Markov Model Treeage Pro 2011, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/markov+model+treeage+pro+2011/markov+model+treeage+pro/pmc10833221-77-7-9
Average 90 stars, based on 1 article reviews

markov model treeage pro 2011 - by Bioz Stars, 2026-11

90/100 stars

Images

other:

Article Title: Model-Based Economic Evaluation of Ceritinib and Platinum-Based Chemotherapy as First-Line Treatments for Advanced Non-Small Cell Lung Cancer in China.
Article Snippet: Introduction: A trial-based assessment was completed to evaluate the cost-effectiveness of ceritinib as a first-line treatment for advanced non-small cell lung cancer (NSCLC) with rearrangement of anaplastic lymphoma kinase.. Methods: Based on the disease situation of advanced NSCLC, a Markov model was constructed to estimate the costs and benefits of ceritinib and platinum-based chemotherapy.. The cost information and health utilities were obtained from published literature.

Article Title: Cost-effectiveness analysis of toripalimab for metastatic or recurrent triple-negative breast cancer
Article Snippet: We established a Markov model with Treeage Pro 2011 (Treeage Software Inc., Williamstown, MA) to evaluate the cost-effectiveness of different treatment strategies.

Article Title: Cost-Utility Analysis of Camrelizumab Plus Chemotherapy Versus Chemotherapy Alone as a First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer in China
Article Snippet: In this study, cost-utility analysis was carried out by constructing and simulating a Markov model run in TreeAge Pro 2011 (TreeAge Software Inc, Williamstown, MA, USA).

Article Title: Cost-effectiveness analysis of cabozantinib as second-line therapy in advanced hepatocellular carcinoma.
Article Snippet: A Markov model using TreeAge Pro 2011 (TreeAge Software) was conducted to simulate patients with sorafenib‐resistant HCC receiv‐ ing either cabozantinib or best supportive care.

Article Title: S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer: a cost-effectiveness analysis
Article Snippet: Model construction A Markov model was developed with TreeAge Pro 2011 (TreeAge Software, Inc., Williamstown, MA, USA) to simulate the disease process of patients with advanced gastric cancer.

Software:

Article Title: Cost-Utility Analysis of Rosuvastatin (20 mg) to Prevent Cardiovascular Diseases in Iran
Article Snippet: .. After drawing the Markov model in TreeAge Pro 2011 software, the incremental cost-effectiveness ratio is obtained by dividing the cost difference by the effectiveness difference. ..

Derivative Assay:

Article Title: Cost-effectiveness of a melanoma screening programme using whole disease modelling.
Article Snippet: .. Table 1 shows the screening-related variables, which were derived from the SCREEN pilot project.19–23 We developed a Markov model using TreeAge Pro 2011 over a time horizon of 25 years, to compare costs and outcomes with and without (usual care) screening (Figure 1(a) to (c)). ..

Infection:

Article Title: Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree
Article Snippet: .. To simulate the long-term outcome of the disease on the entire life of newborns infected with HBV, a Markov model was built using TreeAge Pro 2011. ..

Review